Portosystemic shunting in portal hypertension: evaluation with portal scintigraphy with transrectally administered I-123 IMP.
Portosystemic shunting was evaluated with rectal administration of iodine-123 iodoamphetamine (IMP) in seven patients without liver disease and 53 patients with liver cirrhosis. IMP (2-3 mCi [74-111 MBq]) was administered to the rectum through a catheter. Images of the chest and abdomen were obtained for up to 60 minutes with a scintillation camera interfaced with a computer. In all patients, images of the liver and/or lungs were observed within 5-10 minutes and became clear with time. In patients without liver disease, only liver images could be obtained, whereas the lung was visualized with or without the liver in all patients with liver cirrhosis. The portosystemic shunt index was calculated by dividing counts of lungs by counts of liver and lung. These values were significantly higher in liver cirrhosis, especially in the decompensated stage. Transrectal portal scintigraphy with IMP appears to be a useful method for noninvasive and quantitative evaluation of portosystemic shunting in portal hypertension.
Kashiwagi
T
T
Department of Internal Medicine, Osaka Kosei-Nenkin Hospital, Japan.
Azuma
M
M
Ikawa
T
T
Takehara
T
T
Matsuda
H
H
Yoshioka
H
H
Mitsutani
N
N
Koizumi
T
T
Kimura
K
K
D000285:Administration, Rectal; D000662:Amphetamines / Q000008:administration & dosage; D005260:Female; D006801:Humans; D006975:Hypertension, Portal / Q000000981:diagnostic imaging* / Q000503:physiopathology; D007457:Iodine Radioisotopes / Q000008:administration & dosage; D008099:Liver / Q000000981:diagnostic imaging; D008103:Liver Cirrhosis / Q000000981:diagnostic imaging; D008168:Lung / Q000000981:diagnostic imaging; D008297:Male; D008875:Middle Aged; D011168:Portal System / Q000503:physiopathology*; D011877:Radionuclide Imaging
D000662:Amphetamines; D007457:Iodine Radioisotopes; C041336:4-iodoamphetamine